InvestorsHub Logo
Followers 7
Posts 344
Boards Moderated 0
Alias Born 08/12/2022

Re: None

Wednesday, 08/17/2022 9:26:36 AM

Wednesday, August 17, 2022 9:26:36 AM

Post# of 1456
Imbruvica (ibrutinib) Pharmacyclics (AbbVie) and Janssen (Johnson & Johnson)
2021 Sales $9,777,000,000.00


Data was excellent. Doubled CR of (ABBV) ibrutinib alone in MCL

Data in P53 mutant CCL is game changing

Let this sink in on how valuable this combo is $$$


Anything under $2.00 is a hell of a discount this can quadruple in price in a blink of an eye with a $60 million market cap. Smart money is accumulating for 10-20x gains next 24-36 months. ten 10 drugs in the pipeline this is a Billion dollar plus market cap in the making.

Opportunity for a take over is in the cards two ROR1 acquisitions Merck acquired early clinical data VelsoBio.. for $2.8 Billion & Boehringer buys NBE Therapeutics $1.5Billion ROR1 deal last year.

$ONCT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCT News